Studies on comparative antimicrobial activities of Aerva lanata and Momordica charantia leaf extracts
Abstract
Screening and comparison of antimicrobial action of leaf extract of Aerva lanata and Momordica charantia. Ethyl acetate and methanolic extracts of leaves of plants were screened for antimicrobial activity using the cup plate method and the spread plate method against gram positive and gram negative reference organisms (Bacillus substilis and Escherichia coli).The standard antibacterial agent used for reference is Choramphenicol and the results were calculated as zone of inhibition. Methanolic extract showed comparatively broader and better antimicrobial spectrum than ethyl acetate extract in selected plants. Plant extracts showed dose dependent action, results were similar to the action of the standard Choramphenicol. Extracts of Aerva lanata and Momordica charantia demonstrated antimicrobial activity on tested microorganisms. Methanolic extracts showed higher antimicrobial potential than ethyl acetate extract. Aerva lanata extracts showed better response than Momordica charantia extracts in the cup plate method antibacterial activity with Bacillus substilis and Escherichia coli.
Keywords:
Aerva lanata, Momordica charantia, Methanolic extract, Zone of inhibition, Antimicrobial activity.DOI
https://doi.org/10.25004/IJPSDR.2020.120519References
Mariswamy Y, Gnaraj WE, Antonisamy JM. Chromatographic fingerprint analysis on flavonoids constituents of the medicinally important plant Aerva lanata L. by HPTLC technique. Asian Pac J Trop Biomed. 2011; 1(1):S8-12.
Goyal M, Pareek A, Nagori BP, Sasmal D. Aerva lanata: A review on phytochemistry and pharmacological aspects. Pharmacognosy reviews. 2011; 5(10):195.
Appapalam ST, Panchamoorthy R. Aerva lanata mediated phytofabrication of silver nanoparticles and evaluation of their antibacterial activity against wound associated bacteria. J Taiwan Inst Chem E. 2017; 78:539-51.
Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J. Ethnopharmacol. 1986; 17(3):277-82.
Leelaprakash G, Rose JC, Gowtham BM, Javvaji PK, Prasad SA. In vitro antimicrobial and antioxidant activity of Momordica charantia leaves. Pharmacophore. 2011;2(4):244-52.
Parkash A, Ng TB, Tso WW. Purification and characterization of charantin, a napin‐like ribosome‐inactivating peptide from bitter gourd (Momordica charantia) seeds. Int. J. Pept. Res. Ther. 2002;59(5):197-202.
Ambasta SS. The useful plants of India. CSIR, New Delhi, India: Publications & Information Directorate; 1986.
Okabe H, Miyahara Y, Yamauchi T, Miyahara K, Kawasaki T. Studies on the constituents of Momordica charantia LI Isolation and characterization of momordicosides A and B, glycosides of a pentahydroxy-cucurbitane triterpene. Chem Pharm Bull. 1980;28(9):2753-62.
Ahmed I, Lakhani MS, Gillett M, John A, Raza H. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res. Clin. Pract. 2001;51(3):155-61.
Semiz A, Sen A. Antioxidant and chemoprotective properties of Momordica charantia L.(bitter melon) fruit extract. Afr. J. Biotechnol. 2007;6(3).
Ahmad N, Hassan MR, Halder H, Bennoor KS. Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Bangladesh Med Res Counc Bull. 1999;25(1):11-3.
Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: a review. J. Ethnopharmacol. 2004;93(1):123-32.
Begum S, Ahmed M, Siddiqui BS, Khan A, Saify ZS, Arif M. Triterpenes, a sterol and a monocyclic alcohol from Momordica charantia. Phytochemistry. 1997;44(7):1313-20.
Chang CI, Chen CR, Liao YW, Cheng HL, Chen YC, Chou CH. Cucurbitane-type triterpenoids from the stems of Momordica charantia. J. Nat. Prod;2007;71(8):1327-30.
Akihisa T, Higo N, Tokuda H, Ukiya M, Akazawa H, Tochigi Y, Kimura Y, Suzuki T, Nishino H. Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. J. Nat. Prod. 2007;70(8):1233-9.
Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 2010;8(3):207-17.
Jördening HJ, Winter J, editors. Environmental biotechnology: concepts and applications. John Wiley & Sons; 2005;24.
Mba-Jonas A, Culpepper W, Hill T, Cantu V, Loera J, Borders J, Saathoff-Huber L, Nsubuga J, Zambrana I, Dalton S, Williams I. A multistate outbreak of human Salmonella agona infections associated with consumption of fresh, whole papayas imported from Mexico—United States, 2011. Clin. Infect. Dis. 2018;66(11):1756-61.
Vogt RL, Dippold L. Escherichia coli O157: H7 outbreak associated with consumption of ground beef, June–July 2002. Public health reports. 2005;120(2):174-8.
Bentley R, Meganathan R. Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol. Rev. 1982;46(3):241.
Hudault S, Guignot J, Servin AL. Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut. 2001 ;49(1):47-55.
Published
Abstract Display: 346 
PDF Downloads: 416 
